Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Obesity - Inflammation - Metabolic Disease: Effect of Lactobacillus Casei Shirota

This study has been completed.
Information provided by (Responsible Party):
Vanessa Stadlbauer-Koellner, MD, Medical University of Graz Identifier:
First received: August 13, 2010
Last updated: June 3, 2015
Last verified: June 2015